Mahatme Ujwala has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 35000 shares of Summit Therapeutics Inc. ($SMMT) on January 02, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Mahatme Ujwala | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Summit Therapeutics Inc. | $SMMT | Mahatme Ujwala | Director | A | Stock Option (right to buy) | 52575 | $1.32 | 87,575.0000 | 0 | 150.21% | 0.00% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Mahatme Ujwala | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Summit Therapeutics Inc. | $SMMT | Mahatme Ujwala | Director | A | Stock Option (right to buy) | 40500 | $1.67 | 75,500.0000 | 0 | 115.71% | 0.00% |